Increase in Vascular Permeability and Vasodilation Are Critical for Proangiogenic Effects of Stem Cell Therapy | Zendy

Dong Gil You | Zendy; Ludovic Waeckel | Zendy; Téni G. Ebrahimian | Zendy; Olivier BlancBrude | Zendy; Philippe Foubert | Zendy; Véronique Barateau | Zendy; Micheline Duriez | Zendy; Sophie LeRicousse-Roussanne | Zendy; José Vilar | Zendy; Elisabetta Dejana | Zendy; G Tobelem | Zendy; Bernard Lévy | Zendy; JeanSébastien Silvestre | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increase in Vascular Permeability and Vasodilation Are Critical for Proangiogenic Effects of Stem Cell Therapy

Author(s) -

Dong Gil You,

Ludovic Waeckel,

Téni G. Ebrahimian,

Olivier BlancBrude,

Philippe Foubert,

Véronique Barateau,

Micheline Duriez,

Sophie LeRicousse-Roussanne,

José Vilar,

Elisabetta Dejana,

G Tobelem,

Bernard Lévy,

JeanSébastien Silvestre

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.589937

Subject(s) - progenitor cell , medicine , vasodilation , enos , cd34 , stem cell , vascular permeability , endothelial stem cell , nitric oxide , angiogenesis , arteriogenesis , microbiology and biotechnology , bone marrow , cancer research , immunology , nitric oxide synthase , biology , in vitro , biochemistry

Proangiogenic cell therapy based on administration of bone marrow-derived mononuclear cells (BMCs) or endothelial progenitor cells (EPCs) is now under investigation in humans for the treatment of ischemic diseases. However, mechanisms leading to the beneficial effects of BMCs and EPCs remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research